drugset / Trial / NCT07434115

Orthobiological Therapies in Musculoskeletal Disorders

NCT07434115 ↗

Phase 0 Not yet recruiting 300 enrolled PROREGEN Centro Universitário Univates · collab
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the clinical and functional effects of using orthobiological therapies (hyaluronic acid, platelet-rich plasma, bone marrow aspirate, nanofat, among others) in the treatment of various musculoskeletal diseases in patients routinely treated at the Proregen Medical Clinic and its affiliates. The sample will consist of adult patients (≥18 years), of both sexes, with different musculoskeletal diagnoses involving joints, tendons, ligaments, cartilage or bone, among others.

Timeline

Start
2026-01-30
Primary completion
2029-01
Completion
2030-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bone Marrow Concentrate (BMAC) Unknown — —
Subject Hyaluronic Acid (Viscosupplementation) Unknown — —
Subject Nanofat Unknown — —
Subject PRP injection Unknown — —